-

MetLife Announces New $3 Billion Share Repurchase Authorization

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the $202 million remaining under the company’s prior authorization announced in May 2022.

Commenting on the announcement, MetLife President and CEO Michel Khalaf said: “This new share repurchase authorization combined with the common stock dividend increase we announced in April reflects MetLife’s financial strength and balanced approach to capital management. Taken together, these actions reinforce our commitment to being a sound capital steward for our shareholders.”

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

The forward-looking statements in this news release, using words such as “commitment,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to correct or update any of these statements.

Contacts

For Media:
Brian Blaser
212-578-2415
BBlaser@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

MetLife, Inc.

NYSE:MET

Release Summary
METLIFE ANNOUNCES NEW $3 BILLION SHARE REPURCHASE AUTHORIZATION
Release Versions

Contacts

For Media:
Brian Blaser
212-578-2415
BBlaser@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin’s offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common...

MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will s...

MetLife Appoints Two Experienced Leaders to Board of Directors

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the “Board”), effective immediately. Both leaders bring significant leadership and business experience to their roles. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as president and CEO of Mar...
Back to Newsroom